Communicating prognosis to women with early breast cancer – overview of prediction tools and the development and pilot testing of a decision aid
Open Access
- 15 March 2019
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 19 (1) , 171
Abstract
Shared decision-making in oncology requires information on individual prognosis. This comprises cancer prognosis as well as competing risks of dying due to age and comorbidities. Decision aids usually do not provide such information on competing risks. We conducted an overview on clinical prediction tools for early breast cancer and developed and pilot-tested a decision aid (DA) addressing individual prognosis using additional chemotherapy in early, hormone receptor-positive breast cancer as an example. Systematic literature search on clinical prediction tools for the effects of drug treatment on survival of breast cancer. The DA was developed following criteria for evidence-based patient information and International Patient Decision Aids Standards. We included data on the influence of age and comorbidities on overall prognosis. The DA was pilot-tested in focus groups. Comprehension was additionally evaluated through an online survey with women in breast cancer self-help groups. We identified three prediction tools: Adjuvant!Online, PREDICT and CancerMath. All tools consider age and tumor characteristics. Adjuvant!Online considers comorbidities, CancerMath displays age-dependent non-cancer mortality. Harm due to therapy is not reported. Twenty women participated in focus groups piloting the DA until data saturation was achieved. A total of 102 women consented to participate in the online survey, of which 86 completed the survey. The rate of correct responses was 90.5% and ranged between 84 and 95% for individual questions. None of the clinical prediction tools fulfilled the requirements to provide women with all the necessary information for informed decision-making. Information on individual prognosis was well understood and can be included in patient decision aids.Keywords
Funding Information
- German Federal Ministry of Health (NKP-332-054)
This publication has 71 references indexed in Scilit:
- Accuracy validation of adjuvant! online in Taiwanese breast cancer patients - a 10-year analysisBMC Medical Informatics and Decision Making, 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- The Influence of Comorbidities on Overall Survival Among Older Women Diagnosed With Breast CancerJNCI: Journal of the National Cancer Institute, 2011
- Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerAnnals of Oncology, 2011
- Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IXAnnals of Oncology, 2011
- Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UKBritish Journal of Cancer, 2010
- An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United KingdomBritish Journal of Cancer, 2009
- Developing and evaluating complex interventions: the new Medical Research Council guidanceBMJ, 2008
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- The theory of planned behaviorOrganizational Behavior and Human Decision Processes, 1991